Ambrx Inc logo

AMBX - Ambrx Inc Share Price

n/a 0.0  0.0%

Last Trade -

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £15.6m
Position in Universe th / 8288
Unlock AMBX Revenue
Relative Strength (%)
Volume Change (%)
Price vs... (%)
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2008 2009 2010 2011 2012 2013 2014E 2015E CAGR / Avg
0.000 0.000 0.000 0.000 44.5 17.0 -61.7%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2014, Ambrx Increvenues increased from $2.4M to $5M. Net loss increasedfrom $2.5M to $5.4M. Revenues reflect an increase in demandfor the Company's products and services due to favorablemarket conditions. Higher net loss reflects Research anddevelopment increase from $3.6M to $8.4M (expense), Generaland administrative increase of 25% to $1.8M (expense), Gainon investments decrease from $155K (income) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AMBX Revenue Unlock AMBX Revenue

Net Income

AMBX Net Income Unlock AMBX Revenue

Normalised EPS

AMBX Normalised EPS Unlock AMBX Revenue

PE Ratio Range

AMBX PE Ratio Range Unlock AMBX Revenue

Dividend Yield Range

AMBX Dividend Yield Range Unlock AMBX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2022
31st Dec 2023
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AMBX EPS Forecasts Unlock AMBX Revenue
Profile Summary

Ambrx, Inc. is a United States-based biopharmaceutical company. The Company delivers protein therapeutics using an expanded genetic code to create precision biologics, this includes antibody drug conjugates (ADCs), bispecifics, and targeted immuno-oncology therapies for cancer as well as cytokines to modulate the immune system and therapeutic peptides for metabolic and cardiovascular disease, designed to have improved pharmacologic properties and novel biological activity. The Company's technology platforms combine the conventional medicinal chemistry with cutting edge recombinant DNA-based protein biosynthesis. It also combines site-specific conjugation with linkers, payloads and pharmacokinetic extenders to create a single molecular species.

Last Annual December 31st, 2013
Last Interim March 31st, 2014
Incorporated January 31, 2003
Public Since June 25, 2014
No. of Shareholders: n/a
No. of Employees: 74
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange NASDAQ Global Select Market
Shares in Issue 17,171,371
Free Float (0.0%)
Eligible for
AMBX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AMBX
Upcoming Events for AMBX
Frequently Asked Questions for Ambrx Inc
What is the Ambrx Inc share price?

As of , shares in Ambrx Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Ambrx Inc share price performed this year?

Shares in Ambrx Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ambrx Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Ambrx Inc?

There are no analysts currently covering Ambrx Inc.

When will Ambrx Inc next release its financial results?

Ambrx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2015-03-31
What is the Ambrx Inc dividend yield?

Ambrx Inc does not currently pay a dividend.

Does Ambrx Inc pay a dividend?

Ambrx Inc does not currently pay a dividend.

When does Ambrx Inc next pay dividends?

Ambrx Inc does not currently pay a dividend.

How do I buy Ambrx Inc shares?

To buy shares in Ambrx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ambrx Inc?

Shares in Ambrx Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Ambrx Inc shares listed? Where are Ambrx Inc shares listed?

Here are the trading details for Ambrx Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AMBX
What kind of share is Ambrx Inc?

We were not able to load our ranking data for Ambrx Inc

Is there a Ambrx Inc share price forecast 2022?

We were not able to load any forecast data for Ambrx Inc.

How can I tell whether the Ambrx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ambrx Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Ambrx Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ambrx Inc PE Ratio?

We were not able to find PE ratio data for Ambrx Inc.

Who are the key directors of Ambrx Inc?

Ambrx Inc's management team is headed by:

Simon Allen - OTH
Feng Tian - PRE
Joy Yan - EXO
Dana Zhang - VFN
Shawn Zhang - VPR
Who are the major shareholders of Ambrx Inc?

Here are the top five shareholders of Ambrx Inc based on the size of their shareholding:

Similar to AMBX
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.
{"statusCode":404,"message":"Not Found"}